Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2025-12-27 @ 6:09 AM
Study NCT ID:
NCT03458650
Status:
COMPLETED
Last Update Posted:
2018-05-30
First Post:
2018-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of LuoXin Innovate (LXI-15028) in Healthy Chinese Subjects to Evaluate the Pharmacokinetics, Safety and Tolerability.
Sponsor:
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.